Accessibility Menu
Hlk Biotech Group logo

Hlk Biotech Group(OTC) AMHD

Market Cap$1.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1999)-100%
5 Year-99%
1 Year+0%
1 Month+0%
$0.00
+0%
+0.00Today
Hlk Biotech Group last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-28
Hlk Biotech Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-08
1 month+0%USD 0.002026-06-09
3 month+0%USD 0.002026-04-07
Year to date+0%USD 0.002025-12-30
1 year+0%USD 0.002025-07-17
3 year+100%USD 0.002023-07-24
5 year-99.43%USD 0.042021-07-29
Since inception-100%USD 28,127,812.781999-02-11

Hlk Biotech Group Financials at a Glance

Market Cap

$1.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.61 (Low)

Price

$0.00

Volume

100

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

AMHD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hlk Biotech Group

HLK Biotech Holding Group, Inc. is a company focused on the production and distribution of biodiesel, alongside real estate asset acquisition. Formerly known as Amelot Holdings, Inc., the company rebranded in February 2018 and operates primarily through its subsidiaries.

Products and Services
  • Production and distribution of biodiesel
  • Acquisition and management of real estate assets
  • Engagement in energy sector activities
Growth Outlook
  • Focus on expanding biodiesel production capabilities
  • Strategic investments in real estate to enhance asset portfolio
  • Potential for increased demand in renewable energy markets
Financial Highlights
  • Market capitalization of $925 million indicates significant growth potential
  • Recent trading volume of 2,500 shares reflects active market interest
  • Stock price stability with a range of $0.0002 over the year
HLK Biotech Holding Group, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, positioning itself in the renewable energy sector through biodiesel production. The company’s strategic focus on real estate acquisition complements its core operations, potentially enhancing overall value. The recent market capitalization suggests a strong foundation for future growth, while the consistent stock price indicates stability in a fluctuating market. With a commitment to expanding production capabilities and tapping into the growing demand for renewable energy, HLK Biotech presents an intriguing opportunity for investors interested in sustainable energy solutions.
AI Generated • Jul 14, 2026

Industry

Oil, Gas and Consumable Fuels

Sector

Energy

Headquarters

Norfolk, VA 23517, US

AMHD Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$1.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

4.77M

Volume

100

Avg. Volume

143.29

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Hlk Biotech Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$1.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MMTCMicro Imaging Technology, Inc.
$0.00+0.00%
UTRSMinerva Surgical, Inc.
$0.00+0.00%
CNNXFCannAmerica Brands Corp.
$0.00+0.00%
CALACalithera Biosciences, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$15.25-0.09%
INTCIntel
$81.88-0.05%
NVDANvidia
$190.01-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About AMHD

What is the current price of Hlk Biotech Group?

Hlk Biotech Group is trading at $0.00 per share.

What is the 52-week range for Hlk Biotech Group?

Over the past 52 weeks, Hlk Biotech Group has traded between $0.00 and $0.00.

How much debt does Hlk Biotech Group have?

Hlk Biotech Group total debt is unavailable.

How much cash does Hlk Biotech Group have on hand?

Hlk Biotech Group does not have cash on hand data available.

What is Hlk Biotech Group’s dividend yield?

Hlk Biotech Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.